We understand that as the primary point of contact for patients, caretakers have an integral role in the continued well-being of speech-impaired impatiens. While developing our product, we want to ensure ease for both the patient and their caretaker. We want to ensure that our AR glasses maintain a high degree of ease and accessibility while revolutionizing the SGD market.
There have been minimal changes in SGD technology in recent times. Unfortunately, this has resulted in current devices, such as tablets, lacking a high degree of efficiency in the real world. With 3DHologroup’s new AR glasses, speech-assistive technology will no longer hinder interpersonal interactions. Furthermore, our AR glasses are far better suited to meet the needs of the various speech impairments out there. Their software can train itself to understand the issues the patient is having, and then intelligently respond to them.
We are now entering clinical trials for our product. Qualified patients can participate at no cost. Please contact us for more information on getting involved with our new product!
For more information, and to raise any questions or concerns, please contact us.